Scancell Holdings PLC - ESG Rating & Company Profile powered by AI
Complete ESG assessment of Scancell Holdings PLC can be accessed by logging in. Alternative companies in the rating peer group for Scancell Holdings PLC are shown below. If you work at Scancell Holdings PLC and you would like to licence your ESG aseessment, please contact us.
Scancell Holdings PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.0; made up of an environmental score of 8.0, social score of 6.7 and governance score of 3.4.
6.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 623 | Paion AG | 6.1 | High |
| 623 | Valbiotis SA | 6.1 | High |
| 669 | Scancell Holdings PLC | 6.0 | High |
| 669 | Bachem Holding AG | 6.0 | High |
| 669 | Advaxis Inc | 6.0 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Scancell Holdings PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Scancell Holdings PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Scancell Holdings PLC report the average age of the workforce?
Sign up for free to unlockDoes Scancell Holdings PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Scancell Holdings PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Scancell Holdings PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Scancell Holdings PLC offer flexible work?
Sign up for free to unlockDoes Scancell Holdings PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Scancell Holdings PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Scancell Holdings PLC conduct supply chain audits?
Sign up for free to unlockDoes Scancell Holdings PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Scancell Holdings PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Scancell Holdings PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Scancell Holdings PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Scancell Holdings PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Scancell Holdings PLC disclose water use targets?
Sign up for free to unlockDoes Scancell Holdings PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Scancell Holdings PLC have a product recall in the last two years?
Sign up for free to unlockDoes Scancell Holdings PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Scancell Holdings PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Scancell Holdings PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Scancell Holdings PLC disclose parental leave metrics?
Sign up for free to unlockDoes Scancell Holdings PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Scancell Holdings PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Scancell Holdings PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Scancell Holdings PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Scancell Holdings PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Scancell Holdings PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Scancell Holdings PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Scancell Holdings PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Scancell Holdings PLC disclose its waste policy?
Sign up for free to unlockDoes Scancell Holdings PLC report according to TCFD requirements?
Sign up for free to unlockDoes Scancell Holdings PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Scancell Holdings PLC disclose energy use targets?
Sign up for free to unlockDoes Scancell Holdings PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Scancell Holdings PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Scancell Holdings PLC
These potential risks are based on the size, segment and geographies of the company.
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, which is in phase II clinical trial for the treatment of metastatic melanoma; SCIB2 for the treatment of non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2, which targets homocitrullinated cancer antigens. In addition, the company develops SCOV1 and SCOV2 COVIDITY, a prophylactic DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.